$SGMO
SANGAMO THERAPEUTICS, INC

2014 Q1 Form 10-K Financial Statement

#000119312514065170 Filed on February 24, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q4 2013
Revenue $8.116M $6.869M $24.13M
YoY Change 75.56% -23.09% 11.44%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.640M $4.110M $13.70M
YoY Change 9.97% 36.09% 13.22%
% of Gross Profit
Research & Development $12.08M $10.78M $37.04M
YoY Change 47.0% 16.16% 16.81%
% of Gross Profit
Depreciation & Amortization $123.0K $200.0K $569.0K
YoY Change -16.33% 0.0% -13.79%
% of Gross Profit
Operating Expenses $15.73M $15.04M $50.84M
YoY Change 36.42% 22.3% 15.93%
Operating Profit -$7.611M -$26.71M
YoY Change 10.22% 20.31%
Interest Expense $40.00K $30.00K $100.0K
YoY Change 100.0% -127.27% -200.0%
% of Operating Profit
Other Income/Expense, Net $82.00K
YoY Change -224.24%
Pretax Income -$7.572M -$8.140M -$26.62M
YoY Change 9.9% 133.91% 19.39%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$7.572M -$8.144M -$26.62M
YoY Change 9.98% 134.16% 19.58%
Net Earnings / Revenue -93.3% -118.56% -110.32%
Basic Earnings Per Share
Diluted Earnings Per Share -$119.8K -$131.6K -$475.0K
COMMON SHARES
Basic Shares Outstanding 62.74M shares 61.80M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q1 2013 Q4 2013
SHORT-TERM ASSETS
Cash & Short-Term Investments $213.4M $138.4M $92.80M
YoY Change 272.43% 45.75% 46.14%
Cash & Equivalents $126.8M $10.19M $10.20M
Short-Term Investments $86.60M $128.2M $82.60M
Other Short-Term Assets $349.0K $191.0K $1.000M
YoY Change 16.33% -5.91% 100.0%
Inventory
Prepaid Expenses $370.0K $457.0K
Receivables $5.360M $3.155M $3.200M
Other Receivables $300.0K $300.0K $300.0K
Total Short-Term Assets $220.2M $97.27M $97.30M
YoY Change 258.07% 42.29% 42.25%
LONG-TERM ASSETS
Property, Plant & Equipment $1.410M $1.406M $1.400M
YoY Change -6.0% -8.88% -6.67%
Goodwill $1.585M $1.585M
YoY Change
Intangibles
YoY Change
Long-Term Investments $30.40M $38.70M $38.70M
YoY Change 137.5% 207.14% 207.14%
Other Assets $0.00 $40.00K $0.00
YoY Change
Total Long-Term Assets $35.29M $43.56M $43.50M
YoY Change 146.77% 207.48% 208.51%
TOTAL ASSETS
Total Short-Term Assets $220.2M $97.27M $97.30M
Total Long-Term Assets $35.29M $43.56M $43.50M
Total Assets $255.5M $140.8M $140.8M
YoY Change 237.07% 70.64% 70.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.100M $3.022M $3.000M
YoY Change 144.0% -0.79% 0.0%
Accrued Expenses $1.500M $3.700M $4.400M
YoY Change 36.36% 37.04% 33.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $16.41M $10.13M $10.10M
YoY Change 173.43% 15.26% 14.77%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $20.90M $8.200M $8.200M
YoY Change 151.81% -6.82% -6.82%
Total Long-Term Liabilities $20.90M $8.200M $8.200M
YoY Change 151.81% -6.82% -6.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.41M $10.13M $10.10M
Total Long-Term Liabilities $20.90M $8.200M $8.200M
Total Liabilities $38.08M $19.13M $19.10M
YoY Change 166.26% 8.45% 8.52%
SHAREHOLDERS EQUITY
Retained Earnings -$309.7M -$302.1M
YoY Change 9.66%
Common Stock $678.0K $423.8M
YoY Change 79717.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $217.4M $121.7M $121.7M
YoY Change
Total Liabilities & Shareholders Equity $255.5M $140.8M $140.8M
YoY Change 237.07% 70.64% 70.67%

Cashflow Statement

Concept 2014 Q1 2013 Q4 2013
OPERATING ACTIVITIES
Net Income -$7.572M -$8.144M -$26.62M
YoY Change 9.98% 134.16% 19.58%
Depreciation, Depletion And Amortization $123.0K $200.0K $569.0K
YoY Change -16.33% 0.0% -13.79%
Cash From Operating Activities $11.38M -$1.700M -$19.48M
YoY Change -241.92% -950.0% 141.05%
INVESTING ACTIVITIES
Capital Expenditures $126.0K $0.00 $432.0K
YoY Change 85.29% -100.0% -40.25%
Acquisitions -$79.00K
YoY Change
Other Investing Activities $4.000M -$68.90M -$67.70M
YoY Change -208.11% -1031.08% -664.17%
Cash From Investing Activities $3.887M -$68.90M -$68.12M
YoY Change -204.18% -1070.42% -701.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $7.585M $8.630M
YoY Change 414.92%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 101.4M 500.0K 76.11M
YoY Change 4411.39% -28.57% 4440.99%
NET CHANGE
Cash From Operating Activities 11.38M -1.700M -19.48M
Cash From Investing Activities 3.887M -68.90M -68.12M
Cash From Financing Activities 101.4M 500.0K 76.11M
Net Change In Cash 116.6M -70.10M -11.49M
YoY Change -1327.5% -976.25% -333.93%
FREE CASH FLOW
Cash From Operating Activities $11.38M -$1.700M -$19.48M
Capital Expenditures $126.0K $0.00 $432.0K
Free Cash Flow $11.25M -$1.700M -$19.91M
YoY Change -239.17% -440.0% 126.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
62736879 shares
CY2013Q2 dei Entity Public Float
EntityPublicFloat
405023312
CY2010Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1896000
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
55907000
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10784000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8346190 shares
CY2011Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2750000
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
80132000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16766000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
100000
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53058525 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53058525 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.21
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
339848000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9184346 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2952000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3046000
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
238000
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
88216000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8790000
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
88216000
CY2012Q4 us-gaap Assets
Assets
82533000
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
203000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
8500000
CY2012Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
937000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
26000
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2734000
CY2012Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
CY2012Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1510
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
64896000
CY2012Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
20000
CY2012Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2473000
CY2012Q4 us-gaap Deferred Revenue
DeferredRevenue
CY2012Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4013000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-275509000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2304000
CY2012Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
531000
CY2012Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
94000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
82533000
CY2012Q4 us-gaap Liabilities
Liabilities
17637000
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
8847000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
41868000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
68365000
CY2012Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
73262000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
7375000
CY2012Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
12584000
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
296000
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
73129000
CY2012Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
73288000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21679000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4129000
CY2012Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4495000
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
6770000
CY2012Q4 us-gaap Marketable Securities
MarketableSecurities
73288000
CY2012Q4 us-gaap Other Assets
OtherAssets
41000
CY2012Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
190000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1543000
CY2012Q4 sgmo Accrued Clinical Trial Expense
AccruedClinicalTrialExpense
615000
CY2012Q4 sgmo Deferred Tax Assets Capitalized Research
DeferredTaxAssetsCapitalizedResearch
5000
CY2012Q4 sgmo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
CY2012Q4 sgmo Available For Sale Securities Gross Unrealized Gains Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainsAccumulatedInInvestments
26000
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62243892 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5800931 shares
CY2013Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
8405864 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62243892 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.20
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8405864 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
7.10
CY2013Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
6.84
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
8046932 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.84
CY2013Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
5800931 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
668000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3521000
CY2013Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
748000
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
423209000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
3861000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3022000
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
510000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
709000
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
103107000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10131000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
12000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
496000
CY2013Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
700000
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3182000
CY2013Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
-748000
CY2013Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1570
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
121710000
CY2013Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
CY2013Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
3194000
CY2013Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2013Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1570000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
730000
CY2013Q4 us-gaap Deferred Revenue
DeferredRevenue
-3563000
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4380000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-302133000
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2282000
CY2013Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
-748000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
622000
CY2013Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
121000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
140838000
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
41073000
CY2013Q4 us-gaap Marketable Securities
MarketableSecurities
128224000
CY2013Q4 sgmo Employers Matching Contribution Percentage Towards Employees Contribution
EmployersMatchingContributionPercentageTowardsEmployeesContribution
0.06 pure
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
56425000
CY2013Q4 sgmo Common Stock Exchange Ratio
CommonStockExchangeRatio
1 pure
CY2013Q4 sgmo Accrued Clinical Trial Expense
AccruedClinicalTrialExpense
727000
CY2013Q4 us-gaap Liabilities
Liabilities
19128000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
688000
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
6679000
CY2013Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1570000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
570000
CY2013Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
82627000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
97274000
CY2013Q4 us-gaap Goodwill
Goodwill
1585000
CY2013Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
128212000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
7927000
CY2013Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
38663000
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
320000
CY2013Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
457000
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
81944000
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
199000000
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
103107000
CY2013Q4 us-gaap Assets
Assets
140838000
CY2013Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
128224000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
54849000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10186000
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
11200000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3155000
CY2013Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1870000
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4927000
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
7996000
CY2013Q4 us-gaap Other Assets
OtherAssets
40000
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
191000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
54900000
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
209000000
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1677000
CY2013Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
338000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1406000
CY2013Q4 sgmo Escrow Liability
EscrowLiability
275000
CY2013Q4 sgmo Investments Maturity Dates Available For Sale Securities
InvestmentsMaturityDatesAvailableForSaleSecurities
P2Y
CY2011 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
18000
CY2011 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-139000
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
576000
CY2013Q4 sgmo Deferred Tax Assets Tax Credit Carry Forwards Research State And Local
DeferredTaxAssetsTaxCreditCarryForwardsResearchStateAndLocal
6500000
CY2013Q4 sgmo Deferred Tax Assets Capitalized Research
DeferredTaxAssetsCapitalizedResearch
CY2013Q4 sgmo Restricted Cash And Cash Equivalent
RestrictedCashAndCashEquivalent
300000
CY2013Q4 sgmo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
CY2013Q4 sgmo Available For Sale Securities Gross Unrealized Gains Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainsAccumulatedInInvestments
12000
CY2013Q4 sgmo Stock Split Ratio On Common Stock
StockSplitRatioOnCommonStock
1.33 shares
CY2011 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
50512000 shares
CY2011 us-gaap Stock Dividends Shares
StockDividendsShares
8937 shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.20
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25895000
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.71
CY2011 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1194000
CY2011 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
265000
CY2011 us-gaap Revenues
Revenues
10319000
CY2011 us-gaap Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
100000
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
13000
CY2011 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
589000
CY2011 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35732000
CY2011 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
112974000
CY2011 us-gaap Revenue From Grants
RevenueFromGrants
4209000
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-35821000
CY2011 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
19700000
CY2011 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-6000
CY2011 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
48000
CY2011 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
553000
CY2011 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
71000
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-35750000
CY2011 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
463000
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8081000
CY2011 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50219000
CY2011 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2011 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
0
CY2011 us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
83412000
CY2011 us-gaap Proceeds From Sale Of Investment Projects
ProceedsFromSaleOfInvestmentProjects
10139000
CY2011 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
315000
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14042000
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
51876000
CY2011 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-64000
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1000000
CY2013 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segments
CY2013 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P6Y3M4D
CY2013 us-gaap Business Acquisition Date Of Acquisition Agreement1
BusinessAcquisitionDateOfAcquisitionAgreement1
2013-10-01
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
4400000 shares
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
8081000
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5982000
CY2011 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1772000
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19999000
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32098000
CY2011 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2011 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
646000
CY2011 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8081000
CY2011 us-gaap Operating Expenses
OperatingExpenses
46140000
CY2011 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1576000
CY2011 sgmo Rental Expenses
RentalExpenses
600000
CY2011 sgmo Collaboration Agreements
CollaborationAgreements
6110000
CY2011 sgmo Employee Stock Purchase Plan Rights Weighted Average Estimated Fair Value
EmployeeStockPurchasePlanRightsWeightedAverageEstimatedFairValue
1.62
CY2011 sgmo Proceeds From Issuance Initial Public Offering Net Of Costs
ProceedsFromIssuanceInitialPublicOfferingNetOfCosts
50152000
CY2013 dei Trading Symbol
TradingSymbol
SGMO
CY2013 dei Entity Registrant Name
EntityRegistrantName
SANGAMO BIOSCIENCES INC
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0001001233
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
8.50
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
The RSUs will vest as follows: One-third on second anniversary and two-thirds will vest on the third anniversary of the award date.
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M4D
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.29
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P2Y
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55974000 shares
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.75
CY2013 us-gaap Stock Dividends Shares
StockDividendsShares
167138 shares
CY2013 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.50 pure
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19482000
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.48
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.74
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1119200 shares
CY2013 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M13D
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y18D
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y1M13D
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1715123 shares
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
14900000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
182559 shares
CY2013 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
60
CY2013 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6118000
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
153000
CY2013 us-gaap Revenues
Revenues
24133000
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
2000000
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
160000
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
294000
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26638000
CY2013 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
118894000
CY2013 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-79000
CY2013 us-gaap Revenue From Grants
RevenueFromGrants
2455000
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-26706000
CY2013 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1200000
CY2013 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
100000
CY2013 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
148000
CY2013 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2015000
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1008000
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
82000
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-26624000
CY2013 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
496000
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6146000
CY2013 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
320000
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
69492000
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
432000
CY2013 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-14000
CY2013 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2013 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000
CY2013 us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
51129000
CY2013 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
CY2013 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
721000
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13800000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
76107000
CY2013 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
1500
CY2013 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
60000
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2190000
CY2013 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
269000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
8900000
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
6146000
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-11493000
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8630000
CY2013 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-68118000
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36979000
CY2013 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
569000
CY2013 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2013 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6146000
CY2013 us-gaap Operating Expenses
OperatingExpenses
50839000
CY2013 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
912000
CY2013 sgmo Share Based Compensation Arrangement By Share Based Payment Award Purchase Price Of Common Stock Percent For Specified Stockholder
ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockPercentForSpecifiedStockholder
1.10 pure
CY2013 sgmo Income Tax Expense
IncomeTaxExpense
0
CY2013 sgmo Rental Expenses
RentalExpenses
700000
CY2013 sgmo Collaboration Agreements
CollaborationAgreements
21678000
CY2013 sgmo Employee Stock Purchase Plan Rights Weighted Average Estimated Fair Value
EmployeeStockPurchasePlanRightsWeightedAverageEstimatedFairValue
1.47
CY2013 sgmo Available For Sale Securities Maturity Percentage Next Twelve Months
AvailableForSaleSecuritiesMaturityPercentageNextTwelveMonths
0.70 pure
CY2013 sgmo Share Based Compensation Arrangement By Share Based Payment Award Options Maximum Term For Specified Stock Holder
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTermForSpecifiedStockHolder
P5Y
CY2013 sgmo Available For Sale Securities Maturity Percentage In Next Twelve Months And Year Two
AvailableForSaleSecuritiesMaturityPercentageInNextTwelveMonthsAndYearTwo
0.30 pure
CY2013 sgmo Share Based Compensation Arrangement By Share Based Payment Award Vesting Portion On Second Anniversary
ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPortionOnSecondAnniversary
0.33 pure
CY2013 sgmo Specified Stockholder Ownership Percentage
SpecifiedStockholderOwnershipPercentage
0.10 pure
CY2013 sgmo Share Based Compensation Arrangement By Share Based Payment Award Vesting Portion On Third Anniversary
ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPortionOnThirdAnniversary
0.67 pure
CY2013 sgmo Operating Loss Carryforwards Expiration Year
OperatingLossCarryforwardsExpirationYear
2014
CY2013 sgmo Proceeds From Issuance Initial Public Offering Net Of Costs
ProceedsFromIssuanceInitialPublicOfferingNetOfCosts
69492000
CY2013 sgmo Federal Research Tax Credit Carryforward Expiration Year
FederalResearchTaxCreditCarryforwardExpirationYear
2018
CY2013 sgmo Cash Equivalent Maturity Period Highly Liquid Investment
CashEquivalentMaturityPeriodHighlyLiquidInvestment
Three months or less
CY2013 sgmo Potential Royalty Payments To Entity
PotentialRoyaltyPaymentsToEntity
Two times the amount Sangamo receives in funding under the agreement
CY2013 sgmo Increase Decrease In Escrow Liabilities
IncreaseDecreaseInEscrowLiabilities
275000
CY2013 sgmo Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Value Of Common Stock Issued
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueOfCommonStockIssued
1200000
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y5M16D
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
52741000 shares
CY2012 us-gaap Stock Dividends Shares
StockDividendsShares
0 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.76
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8082000
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.42
CY2012 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1219000
CY2012 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
58000
CY2012 us-gaap Revenues
Revenues
21655000
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-14000
CY2012 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
153000
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22250000
CY2012 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-123000
CY2012 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
91428000
CY2012 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
500000
CY2012 us-gaap Revenue From Grants
RevenueFromGrants
3469000
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-22198000
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
11528000
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2012 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
5400000
CY2012 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-141000
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3414000
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-66000
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-22264000
CY2012 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
457000
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5338000
CY2012 us-gaap Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment
400000
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
723000
CY2012 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
14000
CY2012 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2012 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000
CY2012 us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
103470000
CY2012 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
227000
CY2012 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
800000
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12144000
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1676000
CY2012 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
1000
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
11134000
CY2012 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1503000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
600000
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
5338000
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4913000
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1676000
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11319000
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31709000
CY2012 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
660000
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5338000
CY2012 us-gaap Operating Expenses
OperatingExpenses
43853000
CY2012 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
889000
CY2012 sgmo Rental Expenses
RentalExpenses
600000
CY2012 sgmo Collaboration Agreements
CollaborationAgreements
18186000
CY2012 sgmo Employee Stock Purchase Plan Rights Weighted Average Estimated Fair Value
EmployeeStockPurchasePlanRightsWeightedAverageEstimatedFairValue
2.51
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2013Q1 us-gaap Revenues
Revenues
4623000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-6885000
CY2012Q1 us-gaap Revenues
Revenues
3243000
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-7268000
CY2012Q1 us-gaap Operating Expenses
OperatingExpenses
10526000
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2012Q2 us-gaap Revenues
Revenues
4574000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-5728000
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
10318000
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2013Q2 us-gaap Revenues
Revenues
6934000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-5450000
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
12402000
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2012Q3 us-gaap Revenues
Revenues
4907000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-5790000
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
10709000
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2013Q3 us-gaap Revenues
Revenues
5707000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-6145000
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
11866000
CY2012Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2012Q4 us-gaap Revenues
Revenues
8931000
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-3478000
CY2012Q4 us-gaap Operating Expenses
OperatingExpenses
12300000
CY2013Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2013Q4 us-gaap Revenues
Revenues
6869000
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-8144000
CY2013Q4 us-gaap Operating Expenses
OperatingExpenses
15043000

Files In Submission

Name View Source Status
0001193125-14-065170-index-headers.html Edgar Link pending
0001193125-14-065170-index.html Edgar Link pending
0001193125-14-065170.txt Edgar Link pending
0001193125-14-065170-xbrl.zip Edgar Link pending
d657040d10k.htm Edgar Link pending
d657040dex211.htm Edgar Link pending
d657040dex231.htm Edgar Link pending
d657040dex311.htm Edgar Link pending
d657040dex312.htm Edgar Link pending
d657040dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g657040g38k71.jpg Edgar Link pending
g657040g51t67.jpg Edgar Link pending
g657040g62s27.jpg Edgar Link pending
g657040g80k35.jpg Edgar Link pending
g657040g97x50.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sgmo-20131231.xml Edgar Link completed
sgmo-20131231.xsd Edgar Link pending
sgmo-20131231_cal.xml Edgar Link unprocessable
sgmo-20131231_def.xml Edgar Link unprocessable
sgmo-20131231_lab.xml Edgar Link unprocessable
sgmo-20131231_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending